ArticleVirchows Archiv : an international journal of pathology2026
Anti-NMDAR encephalitis in a patient with possible IgG4-related hypertrophic pachymeningitis: a case report.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IgG4-related hypertrophic pachymeningitis (IgG4-HP) may coexist with autoimmune diseases, malignancies, or infectious diseases. We describe a case of a patient with both possible IgG4-HP and anti-N-methyl-D-aspartate receptor (NMDAR) disease. A 67-year-old woman was admitted to the emergency department due to persistent speech difficulties. An MRI scan of her brain showed diffuse T1-isointense contrast enhancement. High IgG4 concentrations were found in the serum and CSF, and NMDAR antibodies were detected in the CSF. A dura biopsy showed lymphoplasmacytic infiltration of IgG4-positive plasma cells. She was treated with intravenous corticosteroid therapy for five days but was referred to us again approximately one month later due to psychosis and behavioral changes. Corticosteroid therapy was started again, improving her condition. The implications of the coexistence of possible IgG4-HP and anti-NMDAR disease are unclear. An accurate diagnosis of both conditions is needed to avoid suboptimal control of the clinical course. Close collaboration between the involved professionals is warranted.
Indexed as
Identifiers
41984224What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.